384 related articles for article (PubMed ID: 9028455)
1. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
[TBL] [Abstract][Full Text] [Related]
2. [Detection and related analysis to chromosome 22q11 microdeletion in patients with congenital heart diseases].
Xu ZF; Yi L; Mo XM; Hu Y; Wang DJ; Zhu RF; Jiang YZ; Wu X; Wu Z; Shen L; Zhang Y; Zhong XL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):250-5. PubMed ID: 16767657
[TBL] [Abstract][Full Text] [Related]
3. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
4. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
[TBL] [Abstract][Full Text] [Related]
5. Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
Am J Med Genet; 1994 Oct; 52(4):445-9. PubMed ID: 7747757
[TBL] [Abstract][Full Text] [Related]
6. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
[TBL] [Abstract][Full Text] [Related]
7. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch.
Rauch A; Hofbeck M; Leipold G; Klinge J; Trautmann U; Kirsch M; Singer H; Pfeiffer RA
Am J Med Genet; 1998 Jul; 78(4):322-31. PubMed ID: 9714433
[TBL] [Abstract][Full Text] [Related]
8. Classical Noonan syndrome is not associated with deletions of 22q11.
Robin NH; Sellinger B; McDonald-McGinn D; Zackai EH; Emanuel BS; Driscoll DA
Am J Med Genet; 1995 Mar; 56(1):94-6. PubMed ID: 7747795
[TBL] [Abstract][Full Text] [Related]
9. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.
Driscoll DA; Spinner NB; Budarf ML; McDonald-McGinn DM; Zackai EH; Goldberg RB; Shprintzen RJ; Saal HM; Zonana J; Jones MC
Am J Med Genet; 1992 Sep; 44(2):261-8. PubMed ID: 1360769
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
Ravnan JB; Chen E; Golabi M; Lebo RV
Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
[TBL] [Abstract][Full Text] [Related]
11. [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2].
Trost D; Engels H; Bauriedel G; Wiebe W; Schwanitz G
Dtsch Med Wochenschr; 1999 Jan; 124(1-2):3-7. PubMed ID: 9951451
[TBL] [Abstract][Full Text] [Related]
12. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
[TBL] [Abstract][Full Text] [Related]
13. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
14. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo-cardio-facial/DiGeorge syndrome on chromosome 22q11.
Funke B; Pandita RK; Morrow BE
Genomics; 2001 May; 73(3):264-71. PubMed ID: 11350118
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis.
Katzman PJ; Smoot LB; Cox GF
Pediatr Dev Pathol; 2006; 9(4):266-79. PubMed ID: 16944986
[TBL] [Abstract][Full Text] [Related]
17. Neural tube defects and deletions of 22q11.
Nickel RE; Magenis RE
Am J Med Genet; 1996 Dec; 66(1):25-7. PubMed ID: 8957506
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
[TBL] [Abstract][Full Text] [Related]
19. [22q11 microdeletion test in patients with congenital heart defects by quantitative fluorescent PCR].
Chen Y; Mao J; Kwok KY; Kan HJ; Cheng HB; Li HB; Liu MJ; Sun Y; Yan WH; Li H; Choy KW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):571-5. PubMed ID: 20931540
[TBL] [Abstract][Full Text] [Related]
20. [Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome].
Qin YF; Yang JB; Xie CH; Shao J; Zhao ZY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):284-7. PubMed ID: 17557238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
